Found 5 matching trials
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer
PHASE1This study is open to women with recurrent epithelial ovarian carcinoma or ...
Location
University of Pennsylvania
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
N/AThe study is an open-label expanded access study for patients for whom vacc...
Location
University of Arkansas for Medical Sciences
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer
PHASE1Subjects with recurrent epithelial ovarian carcinoma or primary peritoneal ...
Location
University of Pennsylania
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
PHASE2This phase II trial studies the side effects of autologous dendritic cells ...
Location
UCLA / Jonsson Comprehensive Cancer Center
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
PHASE3The primary purpose of the study is to determine the efficacy of an investi...
Location
University of Alabama at Birmingham